• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infect

tetano

Editor, Senior Moderator
Front Immunol


. 2022 Sep 13;13:984784.
doi: 10.3389/fimmu.2022.984784. eCollection 2022.
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections


Suelen H Qassim[SUP] 1 2 3 [/SUP], Mohammad R Hasan[SUP] 4 [/SUP], Patrick Tang[SUP] 4 [/SUP], Hiam Chemaitelly[SUP] 1 2 3 [/SUP], Houssein H Ayoub[SUP] 5 [/SUP], Hadi M Yassine[SUP] 6 7 [/SUP], Hebah A Al-Khatib[SUP] 6 7 [/SUP], Maria K Smatti[SUP] 6 7 [/SUP], Hanan F Abdul-Rahim[SUP] 8 [/SUP], Gheyath K Nasrallah[SUP] 6 7 [/SUP], Mohamed Ghaith Al-Kuwari[SUP] 9 [/SUP], Abdullatif Al-Khal[SUP] 10 [/SUP], Peter Coyle[SUP] 6 10 11 [/SUP], Imtiaz Gillani[SUP] 10 [/SUP], Anvar Hassan Kaleeckal[SUP] 10 [/SUP], Riyazuddin Mohammad Shaik[SUP] 10 [/SUP], Ali Nizar Latif[SUP] 10 [/SUP], Einas Al-Kuwari[SUP] 10 [/SUP], Andrew Jeremijenko[SUP] 10 [/SUP], Adeel A Butt[SUP] 3 10 12 [/SUP], Roberto Bertollini[SUP] 13 [/SUP], Hamad Eid Al-Romaihi[SUP] 13 [/SUP], Mohamed H Al-Thani[SUP] 13 [/SUP], Laith J Abu-Raddad[SUP] 1 2 3 8 [/SUP]



Affiliations
Free PMC article

Abstract

In 2021, Qatar experienced considerable incidence of SARS-CoV-2 infection that was dominated sequentially by the Alpha, Beta, and Delta variants. Using the cycle threshold (Ct) value of an RT-qPCR-positive test to proxy the inverse of infectiousness, we investigated infectiousness of SARS-CoV-2 infections by variant, age, sex, vaccination status, prior infection status, and reason for testing in a random sample of 18,355 RT-qPCR-genotyped infections. Regression analyses were conducted to estimate associations with the Ct value of RT-qPCR-positive tests. Compared to Beta infections, Alpha and Delta infections demonstrated 2.56 higher Ct cycles (95% CI: 2.35-2.78), and 4.92 fewer cycles (95% CI: 4.67- 5.16), respectively. The Ct value declined gradually with age and was especially high for children <10 years of age, signifying lower infectiousness in small children. Children <10 years of age had 2.18 higher Ct cycles (95% CI: 1.88-2.48) than those 10-19 years of age. Compared to unvaccinated individuals, the Ct value was higher among individuals who had received one or two vaccine doses, but the Ct value decreased gradually with time since the second-dose vaccination. Ct value was 2.07 cycles higher (95% CI: 1.42-2.72) for those with a prior infection than those without prior infection. The Ct value was lowest among individuals tested because of symptoms and was highest among individuals tested as a travel requirement. Delta was substantially more infectious than Beta. Prior immunity, whether due to vaccination or prior infection, is associated with lower infectiousness of breakthrough infections, but infectiousness increases gradually with time since the second-dose vaccination.

Keywords: COVID-19; PCR; SARS-CoV-2 variant; breakthrough infection; epidemiology; immunity; reinfection; vaccine.
 
Back
Top Bottom